Kehua Wu

696 total citations
23 papers, 542 citations indexed

About

Kehua Wu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kehua Wu has authored 23 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kehua Wu's work include Cancer therapeutics and mechanisms (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Kehua Wu is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Kehua Wu collaborates with scholars based in United States, China and Hong Kong. Kehua Wu's co-authors include Larry House, Mark J. Ratain, Wanqing Liu, Wei Lu, Jacqueline Ramı́rez, Yong‐Yeon Cho, Michael L. Maitland, Samir D. Undevia, Linda Janisch and Liang Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Kehua Wu

23 papers receiving 534 citations

Peers

Kehua Wu

ONCOL

TRANS

PPCH

Song Ren China

Martine Hubert France

Kevin Rockich United States

Sufia Husain Saudi Arabia

Hongbing Huang China

Emiko Sugiyama Japan

María Santos Spain

Charlotte Costentin France

Greg Bennett Australia

Ronald Honchel United States

Song Ren China

Kehua Wu

155 ×0.7

256 ×1.2

ONCOL

28 ×0.3

TRANS

40 ×0.5

65 ×0.8

PPCH

Citations per year, relative to Kehua Wu Kehua Wu (= 1×) peers Song Ren

Countries citing papers authored by Kehua Wu

Since Specialization

Citations

This map shows the geographic impact of Kehua Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kehua Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kehua Wu more than expected).

Fields of papers citing papers by Kehua Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kehua Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kehua Wu. The network helps show where Kehua Wu may publish in the future.

Co-authorship network of co-authors of Kehua Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Kehua Wu. A scholar is included among the top collaborators of Kehua Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kehua Wu. Kehua Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Kehua, et al.. (2023). Curriculum-reinforcement learning on simulation platform of tendon-driven high-degree of freedom underactuated manipulator. Frontiers in Robotics and AI. 10. 1066518–1066518. 4 indexed citations

Wang, Jian, et al.. (2019). Improving Security Data Access Control for Multi-Authority Cloud Storage. 608–613. 4 indexed citations

Sharma, Manish, Elizabeth Gray, Kehua Wu, et al.. (2017). Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance). The AAPS Journal. 19(5). 1411–1423. 6 indexed citations

Ji, Xiwei, Wei Lu, Kehua Wu, & Yong‐Yeon Cho. (2016). Influencing Factors of the Pharmacokinetic Characters on Nanopharmaceutics. Pharmaceutical Nanotechnology. 5(1). 24–31. 6 indexed citations

Ji, Xiwei, et al.. (2016). Pharmacokinetic-pharmacodynamic modeling of the antitumor effect of TM208 and EGFR-TKI resistance in human breast cancer xenograft mice. Acta Pharmacologica Sinica. 37(6). 825–833. 9 indexed citations

Shang, Dewei, Kehua Wu, Anning Li, et al.. (2016). Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients. International Journal of Clinical Pharmacology and Therapeutics. 54(5). 378–389. 3 indexed citations

Li, Jian, Jingyun Li, Xiwei Ji, et al.. (2015). Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells. Biochemical Pharmacology. 95(2). 98–109. 35 indexed citations

Wu, Kehua, Eric R. Gamazon, Hae Kyung Im, et al.. (2014). Genome-wide Interrogation of Longitudinal FEV1 in Children with Asthma. American Journal of Respiratory and Critical Care Medicine. 190(6). 619–627. 14 indexed citations

Wu, Kehua, et al.. (2014). A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. Acta Pharmacologica Sinica. 36(2). 281–288. 46 indexed citations

10.

Liu, Wanqing, Jacqueline Ramı́rez, Eric R. Gamazon, et al.. (2014). Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver. Human Molecular Genetics. 23(20). 5558–5569. 47 indexed citations

11.

Innocenti, Federico, Richard L. Schilsky, Jacqueline Ramı́rez, et al.. (2014). Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to the UGT1A1 Genotype of Patients With Cancer. Journal of Clinical Oncology. 32(22). 2328–2334. 105 indexed citations

12.

Wu, Kehua, Larry House, Jacqueline Ramı́rez, Michael J. Seminerio, & Mark J. Ratain. (2013). Evaluation of Utility of Pharmacokinetic Studies in Phase I Trials of Two Oncology Drugs. Clinical Cancer Research. 19(21). 6039–6043. 5 indexed citations

13.

Wu, Kehua, R. Stephanie Huang, Larry House, & William C. Cho. (2013). Next-Generation Sequencing for Lung Cancer. Future Oncology. 9(9). 1323–1336. 28 indexed citations

14.

Cohen, Ezra E.W., Kehua Wu, Christine Hartford, et al.. (2012). Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients. Clinical Cancer Research. 18(17). 4785–4793. 51 indexed citations

15.

Sharma, Manish, Soonmo Peter Kang, Theodore Karrison, et al.. (2012). Evaluation of food effect on pharmacokinetics (PK) of GDC-0449 (G) in advanced solid tumor patients.. Journal of Clinical Oncology. 30(15_suppl). e13106–e13106. 3 indexed citations

16.

Wu, Kehua, Tao Guo, Chenhui Deng, et al.. (2012). Population pharmacokinetics of modafinil acid and estimation of the metabolic conversion of modafinil into modafinil acid in 5 major ethnic groups of China. Acta Pharmacologica Sinica. 33(11). 1401–1408. 3 indexed citations

17.

Wu, Kehua, Larry House, Wanqing Liu, & Yong‐Yeon Cho. (2012). Personalized Targeted Therapy for Lung Cancer. International Journal of Molecular Sciences. 13(9). 11471–11496. 54 indexed citations

18.

Gangadhar, Tara C., Ezra E.W. Cohen, Kehua Wu, et al.. (2011). Two Drug Interaction Studies of Sirolimus in Combination with Sorafenib or Sunitinib in Patients with Advanced Malignancies. Clinical Cancer Research. 17(7). 1956–1963. 38 indexed citations

19.

Ramı́rez, Jacqueline, Kehua Wu, Linda Janisch, et al.. (2011). The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients. Cancer Chemotherapy and Pharmacology. 68(6). 1629–1632. 6 indexed citations

20.

Wu, Kehua, et al.. (2005). POPULATION PHARMACOKINETICS OF CYCLOSPORINE IN CLINICAL RENAL TRANSPLANT PATIENTS. Drug Metabolism and Disposition. 33(9). 1268–1275. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact